TransferPoint is an affiliate of Biothera through a series of relationships that are too complex to include here. The technology they use originated with the Donzis patents currently in dispute between Biothera and Immudyne. Dr. Sorgente was, at one time, President and CEO of Immudyne and is very familiar with both companies and their studies.

Agrastim and Purestim are far more biologically active (and more consistently so) than the TransferPoint product that comes from Biothera.

I doubt there is any benefit to sending this information to BIOAGRA, LLC. The "study" has been around for a long time.

Geoff...

Warren Robold is the Director of US and International Sales for BIOAGRA. LLC.

Best regards,

-z